Welcome, Guest. Please login or register.
March 04, 2021, 02:00:15 am

Login with username, password and session length

 

Members
Stats
  • Total Posts: 303
  • Total Topics: 159
  • Online Today: 12
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 10
Total: 10

Welcome!

Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Immunotherapy Benefits Patients With Advanced Merkel Cell Carcinoma  (Read 1302 times)

Offline Cancer Health Editors

  • Jr. Member
  • **
  • Posts: 56
    • View Profile
Before 2016, patients with advanced Merkel cell carcinoma — a rare and extremely deadly skin cancer — had no good treatment options to extend their lives more than a few months. Then, with two pivotal trials, everything changed.

On June 4, investigators presented new, long-term data from these trials that show immunotherapy drugs help a significant subset of patients with this cancer survive much longer than would otherwise be possible. These results crystalize preliminary results from 2016 and 2017 that were promising enough to change the standard of care for MCC and gain a drug approval from the U.S. Food and Drug Administration, the cancer’s first.

Read more...
https://www.cancerhealth.com/article/immunotherapy-benefits-patients-advanced-merkel-cell-carcinoma

 


© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.